Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer - Related Studies

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

This study has been withdrawn prior to recruitment.

Study NCT00093678. Last updated on January 24, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cachexia
		Lymphoma
		Melanoma (Skin)
		Ovarian Cancer
		Pain
		Sarcoma

2	Additional conditions recognized in this trial
		Lymphoma, Non-Hodgkin
		Melanoma
		Ovarian Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Body Weight
		Body Weight Changes
		Emaciation
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Connective and Soft Tissue
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Ovarian Diseases
		Signs and Symptoms
		Urogenital Neoplasms
		Weight Loss

4	Interventions listed in this trial
		celecoxib
		anticachectic therapy
		nutritional support
		pain therapy
		supportive care/therapy

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Cyclooxygenase Inhibitors
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Eastern Cooperative Oncology Group
		National Cancer Institute (NCI)